$67.68 +1.58 (%) AbbVie Inc - NYSE

May. 27, 2015 | 02:30 PM

Partner Headlines

  1. NWQ's First-Quarter Buys and Adds Affect Portfolio

    GuruFocus | May. 26, 2015 | 17:36PM EST
  2. Ambarella Leads 3 Top Stocks Bucking The Sell-Off

    IBD | May. 26, 2015 | 15:20PM EST
  3. This Medical Stock Refuses To Fall With Major Stock Indexes

    IBD | May. 26, 2015 | 13:21PM EST
  4. Stocks Slump On Strong Dollar, Economic Data; AbbVie Rises

    IBD | May. 26, 2015 | 11:57AM EST
  5. AbbVie Makes SEC Filings Relating To Its Previously Announced Agreement and Plan of Reorganization with Pharmacyclics, Inc.

    Benzinga | May. 26, 2015 | 11:47AM EST
  6. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  7. AbbVie Announces Expiration of Hart-Scott-Rodino Waiting Period for AbbVie's Acquisition of Pharmacyclics

    Benzinga | May. 22, 2015 | 08:03AM EST
  8. Benzinga's M&A Chatter for Thursday May 21, 2015

    Benzinga | May. 21, 2015 | 19:08PM EST
  9. Scott Black's Most Heavily Weighted Trades In Q1 2015

    GuruFocus | May. 21, 2015 | 18:58PM EST
  10. What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?

    Benzinga | May. 21, 2015 | 08:27AM EST
  11. Glenview Repeats AbbVie Bull Stance, Shuts Fund To Newbies

    Benzinga | May. 20, 2015 | 15:34PM EST
  12. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  13. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  14. Achillion, J&J To Jointly Develop Hepatitis C Drugs

    IBD | May. 19, 2015 | 17:07PM EST
  15. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga | May. 18, 2015 | 14:17PM EST
  16. U.S. Loves Europe As Pharma, Energy Boost M&A

    IBD | May. 14, 2015 | 17:45PM EST
  17. IPO Outlook: Galapagos Offers New Hope For CF And RA Sufferers

    Benzinga | May. 12, 2015 | 13:45PM EST
  18. Regeneron, Nike Top Big Cap 20 Stocks Near Buy Points

    IBD | May. 11, 2015 | 19:16PM EST
  19. 9 Hot (Or Not) IPOs Scheduled To Debut This Week

    Benzinga | May. 11, 2015 | 08:30AM EST
  20. AbbVie Floats Mega-Bond Deal For Acquisition Funding

    GuruFocus | May. 8, 2015 | 13:38PM EST
  21. Pharmacyclics Posts A Mixed First Quarter Ahead Of Being Acquired By AbbVie

    GuruFocus | May. 7, 2015 | 13:16PM EST
  22. Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers

    Benzinga | May. 5, 2015 | 08:51AM EST
  23. Pharmacyclics tops EPS views

    IBD | May. 1, 2015 | 18:46PM EST
  24. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 18:50PM EST
  25. Obama's Regulators Take Harder Line On Tech Takeovers

    IBD | Apr. 27, 2015 | 18:22PM EST
  26. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  27. AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

    GuruFocus | Apr. 24, 2015 | 14:05PM EST
  28. Biogen Earnings Preview: What To Look For

    IBD | Apr. 23, 2015 | 19:45PM EST
  29. AbbVie Tops, Alexion Misses

    IBD | Apr. 23, 2015 | 18:42PM EST
  30. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  31. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  32. AbbVie Beats Q1 Views, Raises Earnings Outlook

    Benzinga | Apr. 23, 2015 | 09:31AM EST
  33. Earnings Scheduled For April 23, 2015

    Benzinga | Apr. 23, 2015 | 04:03AM EST
  34. Forget Google: 5 Top Stocks With Earnings Thursday

    IBD | Apr. 22, 2015 | 19:31PM EST
  35. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 16:35PM EST
  36. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 10:54AM EST
  37. Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

    Benzinga | Apr. 20, 2015 | 16:09PM EST
  38. Morningstar: Gilead Sciences To Grow Its Hepatitis C Market

    Benzinga | Apr. 18, 2015 | 11:20AM EST
  39. Receptos MS Drug Succeeds Against Ulcerative Colitis

    IBD | Apr. 16, 2015 | 10:50AM EST
  40. New drug trial results positive

    IBD | Apr. 15, 2015 | 18:38PM EST
  41. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD | Apr. 15, 2015 | 11:49AM EST
  42. Solar ETFs Light The Way As Equities Post Broad Gains

    IBD | Apr. 14, 2015 | 18:32PM EST
  43. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 17:48PM EST
  44. Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern

    Benzinga | Apr. 14, 2015 | 14:45PM EST
  45. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 11:12AM EST
  46. AbbVie

    IBD | Apr. 13, 2015 | 18:53PM EST
  47. Chinese Stocks Lead Stock Market Higher

    IBD | Apr. 13, 2015 | 12:03PM EST
  48. AbbVie Upgraded On $7.8 Billion Imbruvica Potential

    IBD | Apr. 13, 2015 | 11:19AM EST
  49. Benzinga's Top Upgrades

    Benzinga | Apr. 13, 2015 | 09:08AM EST
  50. Here's Why Imbruvica Caused BMO To Upgrade AbbVie

    Benzinga | Apr. 13, 2015 | 09:04AM EST
Trading Center